Literature DB >> 27295194

Reliable Diagnosis of Carnitine Palmitoyltransferase Type IA Deficiency by Analysis of Plasma Acylcarnitine Profiles.

M Rebecca Heiner-Fokkema1, Frédéric M Vaz2, Ronald Maatman3, Leo A J Kluijtmans4, Francjan J van Spronsen5, Dirk-Jan Reijngoud6.   

Abstract

BACKGROUND: Carnitine palmitoyltransferase IA (CPT-IA) deficiency is an inherited disorder of the carnitine cycle (MIM #255120). Patients affected by this deficiency might be missed easily because of lack of specific and sensitive biochemical markers. In this study, sensitivity and specificity of plasma free carnitine (C0) and long-chain acylcarnitines (lc-ac: C16:0-, C16:1-, C18:0-, C18:1- and C18:2-ac) was evaluated, including the sum of lc-ac (∑lc-ac) and the molar ratios C0/(C16:0-ac+C18:0-ac) and C0/∑lc-ac.
METHODS: Nine plasma acylcarnitine profiles of 4 CPT-IA deficient patients were compared with profiles of 2,190 subjects suspected of or diagnosed with an inherited disorder of metabolism. Age-dependent reference values were calculated based on the patient population without a definite diagnosis of an inborn error of metabolism (n = 1,600). Sensitivity, specificity, and Receiver Operating Characteristic (ROC) curves were calculated based on samples of the whole patient population.
RESULTS: Concentrations of C0 in plasma were normal in all CPT-IA deficient patient samples. ROC analyses showed highest diagnostic values for C18:0-ac, C18:1-ac, and ∑lc-ac (AUC 1.000) and lowest for C0 (AUC 0.738). Combining two markers, i.e., a plasma C18:1-ac concentration <0.05 μmol/L and a molar ratio of C0/(C16:0-ac+C18:0-ac) >587, specificity to diagnose CPT-IA deficiency increased to 99.3% compared with either C18:1-ac (97.4%) or C0/(C16:0-ac+C18:0-ac) (96.9%) alone, all at a sensitivity of 100%.
CONCLUSIONS: Combination of a low concentration of C18:1-ac with a high molar ratio of C0/(C16:0-ac+C18:0-ac) ratio in plasma has high diagnostic value for CPT-IA deficiency. Patients with a clinical suspicion of CPT-IA deficiency can be diagnosed with this test combination.

Entities:  

Keywords:  Acylcarnitines; Carnitine palmitoyltransferase type IA deficiency; Free carnitine; Plasma; Sensitivity; Specificity

Year:  2016        PMID: 27295194      PMCID: PMC5362552          DOI: 10.1007/8904_2016_564

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  10 in total

1.  Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency.

Authors:  C A Stanley; F Sunaryo; D E Hale; J P Bonnefont; F Demaugre; J M Saudubray
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  ESI-MS/MS measurement of free carnitine and its precursor γ-butyrobetaine in plasma and dried blood spots from patients with organic acidurias and fatty acid oxidation disorders.

Authors:  Sonja Primassin; Ute Spiekerkoetter
Journal:  Mol Genet Metab       Date:  2010-06-25       Impact factor: 4.797

3.  Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy.

Authors:  A M Innes; L E Seargeant; K Balachandra; C R Roe; R J Wanders; J P Ruiter; O Casiro; D A Grewar; C R Greenberg
Journal:  Pediatr Res       Date:  2000-01       Impact factor: 3.756

4.  Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific.

Authors:  R Fingerhut; W Röschinger; A C Muntau; T Dame; J Kreischer; R Arnecke; A Superti-Furga; H Troxler; B Liebl; B Olgemöller; A A Roscher
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

5.  Carnitine palmitoyltransferase I deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile.

Authors:  K G Sim; V Wiley; K Carpenter; B Wilcken
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

Review 6.  Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency.

Authors:  A J Bergman; R A Donckerwolcke; M Duran; J A Smeitink; B Mousson; C Vianey-Saban; B T Poll-The
Journal:  Pediatr Res       Date:  1994-11       Impact factor: 3.756

Review 7.  Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.

Authors:  Jean-Paul Bonnefont; Fatima Djouadi; Carina Prip-Buus; Stephanie Gobin; Arnold Munnich; Jean Bastin
Journal:  Mol Aspects Med       Date:  2004 Oct-Dec

8.  Differences between acylcarnitine profiles in plasma and bloodspots.

Authors:  Monique G M de Sain-van der Velden; Eugene F Diekman; Judith J Jans; Maria van der Ham; Berthil H C M T Prinsen; Gepke Visser; Nanda M Verhoeven-Duif
Journal:  Mol Genet Metab       Date:  2013-04-13       Impact factor: 4.797

9.  Neonatal screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in The Netherlands: the importance of enzyme analysis to ascertain true MCAD deficiency.

Authors:  T G J Derks; T S Boer; A van Assen; T Bos; J Ruiter; H R Waterham; K E Niezen-Koning; R J A Wanders; J M M Rondeel; J G Loeber; L P Ten Kate; G P A Smit; D-J Reijngoud
Journal:  J Inherit Metab Dis       Date:  2008-01-14       Impact factor: 4.982

10.  Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project.

Authors:  David M S McHugh; Cynthia A Cameron; Jose E Abdenur; Mahera Abdulrahman; Ona Adair; Shahira Ahmed Al Nuaimi; Henrik Åhlman; Jennifer J Allen; Italo Antonozzi; Shaina Archer; Sylvia Au; Christiane Auray-Blais; Mei Baker; Fiona Bamforth; Kinga Beckmann; Gessi Bentz Pino; Stanton L Berberich; Robert Binard; François Boemer; Jim Bonham; Nancy N Breen; Sandra C Bryant; Michele Caggana; S Graham Caldwell; Marta Camilot; Carlene Campbell; Claudia Carducci; Sandra C Bryant; Michele Caggana; S Graham Caldwell; Marta Camilot; Carlene Campbell; Claudia Carducci; Rohit Cariappa; Clover Carlisle; Ubaldo Caruso; Michela Cassanello; Ane Miren Castilla; Daisy E Castiñeiras Ramos; Pranesh Chakraborty; Ram Chandrasekar; Alfredo Chardon Ramos; David Cheillan; Yin-Hsiu Chien; Thomas A Childs; Petr Chrastina; Yuri Cleverthon Sica; Jose Angel Cocho de Juan; Maria Elena Colandre; Veronica Cornejo Espinoza; Gaetano Corso; Robert Currier; Denis Cyr; Noemi Czuczy; Oceania D'Apolito; Tim Davis; Monique G de Sain-Van der Velden; Carmen Delgado Pecellin; Iole Maria Di Gangi; Cristina Maria Di Stefano; Yannis Dotsikas; Melanie Downing; Stephen M Downs; Bonifacio Dy; Mark Dymerski; Inmaculada Rueda; Bert Elvers; Roger Eaton; Barbara M Eckerd; Fatma El Mougy; Sarah Eroh; Mercedes Espada; Catherine Evans; Sandy Fawbush; Kristel F Fijolek; Lawrence Fisher; Leifur Franzson; Dianne M Frazier; Luciana R C Garcia; Maria Sierra García-Valdecasas Bermejo; Dimitar Gavrilov; Rosemarie Gerace; Giuseppe Giordano; Yolanda González Irazabal; Lawrence C Greed; Robert Grier; Elyse Grycki; Xuefan Gu; Fizza Gulamali-Majid; Arthur F Hagar; Lianshu Han; W Harry Hannon; Christa Haslip; Fayza Abdelhamid Hassan; Miao He; Amy Hietala; Leslie Himstedt; Gary L Hoffman; William Hoffman; Philis Hoggatt; Patrick V Hopkins; David M Hougaard; Kerie Hughes; Patricia R Hunt; Wuh-Liang Hwu; June Hynes; Isabel Ibarra-González; Cindy A Ingham; Maria Ivanova; Ward B Jacox; Catharine John; John P Johnson; Jón J Jónsson; Eszter Karg; David Kasper; Brenda Klopper; Dimitris Katakouzinos; Issam Khneisser; Detlef Knoll; Hirinori Kobayashi; Ronald Koneski; Viktor Kozich; Rasoul Kouapei; Dirk Kohlmueller; Ivo Kremensky; Giancarlo la Marca; Marcia Lavochkin; Soo-Youn Lee; Denis C Lehotay; Aida Lemes; Joyce Lepage; Barbara Lesko; Barry Lewis; Carol Lim; Sharon Linard; Martin Lindner; Michele A Lloyd-Puryear; Fred Lorey; Yannis L Loukas; Julie Luedtke; Neil Maffitt; J Fergall Magee; Adrienne Manning; Shawn Manos; Sandrine Marie; Sônia Marchezi Hadachi; Gregg Marquardt; Stephen J Martin; Dietrich Matern; Stephanie K Mayfield Gibson; Philip Mayne; Tonya D McCallister; Mark McCann; Julie McClure; James J McGill; Christine D McKeever; Barbara McNeilly; Mark A Morrissey; Paraskevi Moutsatsou; Eleanor A Mulcahy; Dimitris Nikoloudis; Bent Norgaard-Pedersen; Devin Oglesbee; Mariusz Oltarzewski; Daniela Ombrone; Jelili Ojodu; Vagelis Papakonstantinou; Sherly Pardo Reoyo; Hyung-Doo Park; Marzia Pasquali; Elisabetta Pasquini; Pallavi Patel; Kenneth A Pass; Colleen Peterson; Rolf D Pettersen; James J Pitt; Sherry Poh; Arnold Pollak; Cory Porter; Philip A Poston; Ricky W Price; Cecilia Queijo; Jonessy Quesada; Edward Randell; Enzo Ranieri; Kimiyo Raymond; John E Reddic; Alejandra Reuben; Charla Ricciardi; Piero Rinaldo; Jeff D Rivera; Alicia Roberts; Hugo Rocha; Geraldine Roche; Cheryl Rochman Greenberg; José María Egea Mellado; María Jesús Juan-Fita; Consuelo Ruiz; Margherita Ruoppolo; S Lane Rutledge; Euijung Ryu; Christine Saban; Inderneel Sahai; Maria Isabel Salazar García-Blanco; Pedro Santiago-Borrero; Andrea Schenone; Roland Schoos; Barb Schweitzer; Patricia Scott; Margretta R Seashore; Mary A Seeterlin; David E Sesser; Darrin W Sevier; Scott M Shone; Graham Sinclair; Victor A Skrinska; Eleanor L Stanley; Erin T Strovel; April L Studinski Jones; Sherlykutty Sunny; Zoltan Takats; Tijen Tanyalcin; Francesca Teofoli; J Robert Thompson; Kathy Tomashitis; Mouseline Torquado Domingos; Jasmin Torres; Rosario Torres; Silvia Tortorelli; Sandor Turi; Kimberley Turner; Nick Tzanakos; Alf G Valiente; Hillary Vallance; Marcela Vela-Amieva; Laura Vilarinho; Ulrika von Döbeln; Marie-Francoise Vincent; B Chris Vorster; Michael S Watson; Dianne Webster; Sheila Weiss; Bridget Wilcken; Veronica Wiley; Sharon K Williams; Sharon A Willis; Michael Woontner; Katherine Wright; Raquel Yahyaoui; Seiji Yamaguchi; Melissa Yssel; Wendy M Zakowicz
Journal:  Genet Med       Date:  2011-03       Impact factor: 8.822

  10 in total
  3 in total

1.  Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression.

Authors:  Siamak MahmoudianDehkordi; Ahmed T Ahmed; Sudeepa Bhattacharyya; Xianlin Han; Rebecca A Baillie; Matthias Arnold; Michelle K Skime; Lisa St John-Williams; M Arthur Moseley; J Will Thompson; Gregory Louie; Patricio Riva-Posse; W Edward Craighead; William McDonald; Ranga Krishnan; A John Rush; Mark A Frye; Boadie W Dunlop; Richard M Weinshilboum; Rima Kaddurah-Daouk
Journal:  Transl Psychiatry       Date:  2021-03-02       Impact factor: 6.222

2.  Enhancement of Acylcarnitine Levels in Small Intestine of Abdominal Irradiation Rats Might Relate to Fatty Acid β-Oxidation Pathway Disequilibration.

Authors:  Hai-Xiang Liu; Xue Lu; Hua Zhao; Shuang Li; Ling Gao; Mei Tian; Qing-Jie Liu
Journal:  Dose Response       Date:  2022-02-22       Impact factor: 2.658

3.  Newborn Screening for Mitochondrial Carnitine-Acylcarnitine Cycle Disorders in Zhejiang Province, China.

Authors:  Duo Zhou; Yi Cheng; Xiaoshan Yin; Haixia Miao; Zhenzhen Hu; Jianbin Yang; Yu Zhang; Benqing Wu; Xinwen Huang
Journal:  Front Genet       Date:  2022-03-14       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.